Please use symbol entry at top right of page to search

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • Genocea Biosciences NASDAQ:GNCA shares moved upwards by 70.9% to $0.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.1 million.
  • Motus GI Hldgs NASDAQ:MOTS shares rose 32.85% to $0.34. The market value of their outstanding shares is at $18.8 million.
  • Cingulate NASDAQ:CING stock increased by 15.04% to $1.3. The market value of their outstanding shares is at $14.7 million.
  • AcelRx Pharmaceuticals NASDAQ:ACRX shares increased by 12.2% to $0.25. The company's market cap stands at $36.7 million.
  • Aprea Therapeutics NASDAQ:APRE shares moved upwards by 10.71% to $0.74. The company's market cap stands at $16.2 million.
  • Vallon Pharmaceuticals NASDAQ:VLON shares moved upwards by 10.55% to $0.57. The market value of their outstanding shares is at $5.9 million.

Losers

  • Verrica Pharmaceuticals NASDAQ:VRCA stock declined by 54.9% to $2.51 during Wednesday's pre-market session. The company's market cap stands at $69.0 million.
  • Roivant Sciences NASDAQ:ROIV stock decreased by 13.3% to $3.39. The market value of their outstanding shares is at $2.3 billion.
  • NexGel NASDAQ:NXGL stock fell 12.86% to $1.22. The market value of their outstanding shares is at $6.7 million.
  • Better Therapeutics NASDAQ:BTTX stock fell 12.33% to $1.92. The market value of their outstanding shares is at $45.3 million.
  • BIMI Intl Medical NASDAQ:BIMI shares declined by 10.98% to $0.56. The company's market cap stands at $5.7 million. As per the press release, Q1 earnings came out 3 days ago.
  • Soligenix NASDAQ:SNGX stock decreased by 10.49% to $0.51. The market value of their outstanding shares is at $21.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Search News

Filter Results

Publication Date
Topic
Provider
  • All

News, commentary and research reports are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.